Osteoarthritis is the most common type of arthritis and the major cause of chronic disability in musculoskeletal mobility in the elderly populations worldwide. In this study, the scaffold free autologous platelet rich plasma (PRP) in an experimental animal model of osteoarthritis (OA) by direct intra articular injection was used.
Introduction
Osteoarthritis (OA) is a highly prevalent disease and the prevalence increases with age as a result of urbanization and increased longevity. Hayes et al (2005) found that the OA-related complaints are very common. Jimenez et al (1995) reported that the osteoarthritis (OA) is a progressively debilitating disease that affects mostly cartilage, with associated changes in the bone. The lack of therapeutic choices has led to focus on the potential of platelet rich plasma as a new strategy for cartilage repair. In this study, the scaffold free autogenous platelet rich plasma (PRP) in an experimental animal model of OA by direct intra articular injection was used.
Materials and Methods
Preparation of PRP: Four milliliter blood was collected from the jugular vein of each rabbit into a sodium citrate tube. The tubes were centrifuged at 1240 rpm for eight minutes. The tubes showed three different density compartment, the lower red blood cells, the middle buffy coat of white blood cells, and the top plasma. The plasma had three distinct layers in ratio of 2:1:1 from the top. The first top layer was platelet poor plasma (PPP), the middle plasma average platelet (PAP) and the lower platelet rich plasma (PRP). The first (PPP) and the second (PAP) were removed by pipette. The third (PRP) layer was carefully separated by pipette and centrifuged again for 5 minutes at the same speed. Then the first layer (plasma) was discarded and the second layer (PRP) was collected for intra articular injection in the OA joints.
Surgical procedure:
The study was approved by institutional ethical committee. Seventeen adult New Zealand white rabbits weighing 2.22±0.12 kg were used. The rabbits were anesthetized by intramuscular administration of 10 mg/kg of Xylazine (Rompun, Bayer AG, Leverkusen) and 50 mg/kg of ketamine (Alfasan, WoerdenHoland). The knee was placed in full flexion and under aseptic conditions through the skin incision in the medial para-patellar area of the left knee the patella was displaced laterally and the anterior cruciate ligament was transected (ACLT). The joint capsule and subcutaneous tissue were closed using 3-0 Polydioxanone suture (ETHICON, INC). The skin was closed using silk suture (SUPA, Iran). Following surgery, rabbits were treated by a standard antibiotic (Penicillin, Zakaria laboratory Tabriz, Iran), and analgesic (Flunixin, Razak laboratories, Tehran-Iran). They were allowed to resume normal cage activity for 8 weeks.
PRP injection: Ten out of 17 rabbits were anesthetized at the end of 8 weeks following surgery. The knee joint was prepared for aseptic injection. 0.5 ml PRP was injected into the medial compartment of the operated joint. The remaining 7 rabbits served as the control group and received no injection. All the rabbits were allowed unrestricted cage activity without immobilization until sacrifice.
Pathologic evaluation: At the 12th week after the initial surgery five rabbits from the treatment group and three rabbits from the control group were euthanized using sodium thiopental overdose. At 16th week post surgery, the remaining rabbits in treatment group and control group were also euthanized. The knee tissues were fixed into 10% buffered formalin. Then the specimens were kept in 7% nitric acid for 48 to 72 hours to allow the decalcification process. Samples were cut in frontal plan, so that femur and tibia and joint space in between could be seen in a single plane. Samples were stained by toluidine blue solution (2% Grade 4: tear extending in to the bone Glycoprotein content was measured by using tide mark level of cartilage (boundary between glycoprotein layer and calcified cartilage) as a guideline. The collagen staining quality was assessed by toluidine blue. Assessment of cartilage cell distribution was performed by evaluating pattern of distribution as: columnar, columnar and cluster, cluster. Live chondrocyte proportion was measured by counting cartilage lacunae that contained visible chondrocytes with intact nucleus and cell membrane in five different randomly chosen areas. 
Results
Results of measured data in treatment and control groups at 12th and 16th week are summarized in tables 2 and 3 and in histograms 1 and 2. is derived from these biological properties. Gruber et al, (2002) said that platelets and thrombin activated platelet products induced mitogenic activity of cultured human trabecular bone-derived cells and that platelet concentrates also enhance the proliferation of human osteoblast like cells. PRP would increase demineralized bone matrix osteoinductivity in vivo. Chondrogenesis has been observed in 2 weeks and osteogenesis in 4 weeks in the non activated PRP cohort. Han et al, (2009) reported that thrombin activation would yield inflammatory cells that were not seen in the non activated group. Hurst and Bazan, (1995) reported that the platelet-activating factor (PAF) produces several biochemical responses associated with inflammation and wound healing. Bazan and Tao, (1997) mentioned that it also activates mitogen-activated protein kinases and stimulates both calcium influx into cells and the expression of the cyclooxygenease (COX-2) enzyme, an inducible isoform responsible for synthesis of various prostaglandins associated with inflammation. In a research by Bazan et al, (1993) , Tao et al, (1995) and Tao et al, (1996) the PAF activates the gene expression of selective metalloproteinases (MMPs) involved in tissue remodeling, such as MMP-1 and MMP-9, urokinase plasminogen activator (uPA), and their inhibitors.
This study described process of development of Osteoarthritis (OA) in rabbits by pathological investigation and also the effects of platelet rich plasma on repair process and conversion of osteoarthritis changes to normal articular structure. Bone alterations in an advanced OA include subchondral cysts and formation of osteophyte. However, Findlay (2007) believed that the lack of understanding of the underlying cause(s) for OA mean that treatments remain largely palliative. Goldring and Goldring (2006) mentioned that as OA progresses, there is evidence of vascular invasion and advancement of this zone of calcified cartilage into the articular cartilage that further contributes to a decrease in articular cartilage thickness. Platelet-derived Growth Factors (GFs) enhance tissue repair mechanisms such as angiogenesis, extracellular matrix remodeling, and cellular effects as stem cells recruitment, chemotaxis, cell proliferation and differentiation due to their biologically active peptides. Platelet growth factors have proved a certain therapeutic modality, offering opportunities for treatment of soft-tissue injuries, cutaneous wounds, ulcers, and more in cell therapy. Ahmad et al, (2012) reported that the Platelet rich plasma (PRP) is an autologous blood-derived product that has an increased concentration of platelets that are rich in growth factors, and has the potential to enhance the healing of tissue at the cellular level via the recruitment, proliferation, and differentiation of cells involved in tissue regeneration Gotterbarm et al, (2006) said the platelet-rich plasma (PRP) acts as a rich source of autologous growth factors. Thus Sun et al, (2010) mentioned that, PRP is a very good clinical source for osteochondral regeneration. Shin et al, (2012) proved that PRP was effective in normal tissue regeneration. But there is no clue that platelet rich plasma would normalize the diabetic wound healing pathway. In a study Madlener et al, (1998) observed an extracellular matrix-regulating effect of PRP. In this study the beneficial effects of PRP were observed in the OA joints.
